Your browser is no longer supported. Please, upgrade your browser.
Settings
INVA Innoviva, Inc. daily Stock Chart
INVA [NASD]
Innoviva, Inc.
Index- P/E3.92 EPS (ttm)3.31 Insider Own0.10% Shs Outstand98.35M Perf Week-0.92%
Market Cap1.28B Forward P/E9.57 EPS next Y1.36 Insider Trans0.00% Shs Float68.35M Perf Month7.46%
Income375.10M PEG0.20 EPS next Q0.50 Inst Own74.80% Short Float16.87% Perf Quarter15.19%
Sales264.90M P/S4.82 EPS this Y211.30% Inst Trans-5.47% Short Ratio18.57 Perf Half Y-7.36%
Book/sh2.64 P/B4.91 EPS next Y-20.53% ROA61.10% Target Price13.50 Perf Year-26.35%
Cash/sh3.02 P/C4.29 EPS next 5Y19.34% ROE179.60% 52W Range10.03 - 20.54 Perf YTD-25.67%
Dividend- P/FCF5.06 EPS past 5Y68.70% ROI81.00% 52W High-36.85% Beta1.51
Dividend %- Quick Ratio110.20 Sales past 5Y124.90% Gross Margin- 52W Low29.31% ATR0.35
Employees6 Current Ratio110.20 Sales Q/Q6.60% Oper. Margin94.40% RSI (14)62.39 Volatility3.28% 2.52%
OptionableYes Debt/Eq0.00 EPS Q/Q-15.50% Profit Margin- Rel Volume0.79 Prev Close13.07
ShortableYes LT Debt/Eq1.45 EarningsOct 30 Payout0.00% Avg Volume621.05K Price12.97
Recom- SMA203.01% SMA5012.30% SMA2000.32% Volume492,147 Change-0.77%
Nov-20-17Initiated Deutsche Bank Hold $13
Dec-05-19 10:02AM  Ra Pharmaceuticals Begins Phase II Study on Autoimmune Drug Zacks
Dec-03-19 09:36AM  Top Ranked Value Stocks to Buy for December 3rd Zacks
Nov-27-19 03:32AM  Sorrento Turns Down Two All-Cash Takeover Bids, Stock Jumps Zacks
Nov-25-19 09:18AM  Alexion Gets Approval for Label Expansion of Soliris in Japan Zacks
Nov-13-19 10:20AM  Surging Earnings Estimates Signal Upside for Innoviva (INVA) Stock Zacks
Nov-12-19 08:00AM  Value ETFs & Stocks Offering Real Value: 5 Top Picks Zacks
Oct-30-19 04:05PM  Innoviva Reports Third Quarter 2019 Financial Results Business Wire
Oct-26-19 12:36PM  Is Innoviva, Inc. (INVA) Going To Burn These Hedge Funds ? Insider Monkey
Oct-09-19 07:15AM  How Many Innoviva, Inc. (NASDAQ:INVA) Shares Did Insiders Buy, In The Last Year? Simply Wall St.
Oct-02-19 09:17AM  GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma Business Wire
Jul-24-19 04:05PM  Innoviva Reports Second Quarter 2019 Financial Results Business Wire
Jul-11-19 11:19AM  Moleculin Files New Patents for Cancer Candidate Annamycin Zacks
06:17AM  Does The Data Make Innoviva, Inc. (NASDAQ:INVA) An Attractive Investment? Simply Wall St.
Jun-18-19 09:25AM  Celgene (CELG) Hits 52-Week High, Can the Run Continue? Zacks
Jun-11-19 09:40AM  How Does Innoviva, Inc. (NASDAQ:INVA) Affect Your Portfolio Volatility? Simply Wall St.
May-23-19 09:19AM  The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology Zacks
May-22-19 07:21AM  5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon Zacks
May-15-19 10:20AM  Earnings Estimates Moving Higher for Innoviva (INVA): Time to Buy? Zacks
09:35AM  New Strong Buy Stocks for May 15th Zacks
May-02-19 01:46PM  GSK's 3-in-1 inhalable drug shows promise in asthma study Reuters +7.10%
12:18PM  Phase III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma Meets Primary Endpoint Business Wire
May-01-19 07:52PM  Innoviva: 1Q Earnings Snapshot Associated Press
04:09PM  Innoviva Reports First Quarter 2019 Financial Results Business Wire
Apr-30-19 03:43PM  Is Innoviva, Inc. (INVA) A Good Stock To Buy? Insider Monkey
Apr-24-19 03:23PM  Those Who Purchased Innoviva (NASDAQ:INVA) Shares Five Years Ago Have A 49% Loss To Show For It Simply Wall St.
Apr-08-19 10:00AM  3 Top Biotech Stocks to Buy in April Motley Fool
Mar-08-19 08:00PM  A Dozen 13D Deals Barrons.com
02:21PM  How Many Insiders Bought Innoviva, Inc. (NASDAQ:INVA) Shares? Simply Wall St.
Feb-19-19 05:48PM  Innoviva Inc (INVA) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Feb-15-19 04:27PM  Innoviva, Inc. -- Moody's announces completion of a periodic review of ratings of Innoviva, Inc. Moody's
Feb-07-19 02:39PM  Buy the Dip on This Pharma Stock Schaeffer's Investment Research
Feb-06-19 05:57PM  Innoviva: 4Q Earnings Snapshot Associated Press -6.00%
04:05PM  Innoviva Reports Fourth Quarter 2018 Financial Results Business Wire
08:15AM  Report: Developing Opportunities within Xcel Energy, Empire State Realty Trust, Innoviva, Tyler Technologies, Tower International, and Nathan's Famous Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-30-19 04:09PM  Mylan Pops After FDA Approves Its Knockoff Of Glaxo's Asthma Inhaler Investor's Business Daily -9.17%
Jan-22-19 01:37PM  Why Innoviva, Inc. (NASDAQ:INVA) Is An Attractive Investment To Consider Simply Wall St.
Jan-11-19 03:30PM  Dow Jones Gives Back Little Of Its 1,100-Point Rebound; 3 Signs Stock Market Bears Are Retreating Investor's Business Daily
Jan-01-19 09:21AM  3 Under-the-Radar Value Stocks to Buy in 2019 Motley Fool
Dec-20-18 09:30AM  Is Innoviva (INVA) Stock Outpacing Its Medical Peers This Year? Zacks
Dec-17-18 03:10PM  IBD 50 Stocks To Watch: Innoviva Resilient As Broad Market Struggles Investor's Business Daily
Dec-14-18 12:39AM  Hedge Funds Arent Crazy About Innoviva, Inc. (INVA) Anymore Insider Monkey
Dec-06-18 09:37AM  3 Reasons Momentum Stock Investors Will Love Innoviva (INVA) Zacks
Nov-23-18 12:03PM  Stocks Trim Losses As Consumer Stocks Rise At Start Of Holiday Shopping Season Investor's Business Daily +5.39%
Nov-20-18 04:25PM  IBD Stock Of The Day Breezes Toward Breakout On New Inhaler Uses Investor's Business Daily
Nov-13-18 09:22AM  Glaxo/Innoviva's Trelegy Ellipta Gets Line Extension in Europe Zacks
Nov-09-18 07:56AM  Moving Average Crossover Alert: Innoviva (INVA) Zacks
07:01AM  Once-daily Trelegy Ellipta gains expanded COPD indication in Europe Business Wire
Nov-06-18 07:30AM  Research Report Identifies Oil States International, Brightcove, Electronics for Imaging, Cirrus Logic, Innoviva, and Marinus Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-05-18 03:01PM  IBD 50 Stocks To Watch: This Stock Rallied Despite A Miss On Earnings And Revenue Investor's Business Daily
Oct-31-18 04:31PM  Innoviva: 3Q Earnings Snapshot Associated Press -6.31%
04:05PM  Innoviva Reports Third Quarter 2018 Financial Results Business Wire
Sep-21-18 07:30AM  Trelegy Ellipta Receives Positive CHMP Opinion Supporting Expanded COPD Indication in Europe Business Wire
Sep-05-18 02:57PM  Should You Be Worried When Innoviva Incs (NASDAQ:INVA) Insiders Sell? Simply Wall St.
Aug-28-18 07:35AM  Report: Exploring Fundamental Drivers Behind Allscripts Healthcare Solutions, Dean Foods, Alder BioPharmaceuticals, Innoviva, Chegg, and TEGNA New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jul-26-18 04:05PM  Innoviva Reports Second Quarter 2018 Financial Results Business Wire
Jul-17-18 12:33PM  GlaxoSmithKline Is More Than Just a 5% Dividend Income Play InvestorPlace
Jul-13-18 07:30AM  Free Technical Research on Insmed and Three More Biotech Equities ACCESSWIRE
Jun-26-18 12:02PM  Innoviva And Other Great Growth Stocks Simply Wall St.
07:55AM  Recent Analysis Shows Church & Dwight Co., Innoviva, PTC Therapeutics, KBR, Murphy Oil, and F.N.B. Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jun-15-18 10:21AM  3 Top Healthcare Stocks to Buy in June Motley Fool
Jun-11-18 07:38AM  The Cheapest Drug Stocks to Buy Right Now Motley Fool
May-30-18 10:33AM  Glaxo/Innoviva File for Approval of Trelegy Ellipta in Japan Zacks
May-29-18 02:00AM  GSK Submits Regulatory Application in Japan for Once-Daily Single Inhaler Triple Therapy FF/UMEC/VI for Patients with COPD Business Wire
May-22-18 04:05PM  Innoviva Names Geoffrey Hulme as Interim Principal Executive Officer Business Wire
May-14-18 10:02AM  Top Cheap Stocks To Buy Simply Wall St.
May-08-18 08:25AM  Research Report Identifies ILG, Innoviva, iRobot, KBR, KapStone Paper and Packaging, and Lumentum with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
May-01-18 07:50AM  Blog Exposure - INSYS Commences Phase-2 Clinical Trial of Cannabidiol Oral Solution for Treatment of Prader-Willi Syndrome ACCESSWIRE
Apr-26-18 08:23AM  Innoviva: 1Q Earnings Snapshot Associated Press
08:00AM  Innoviva Reports First Quarter 2018 Financial Results Business Wire
Apr-24-18 12:55PM  Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients With COPD Business Wire
Apr-18-18 05:00PM  Landmark IMPACT Study Published in NEJM Shows Significant Benefits of Trelegy Ellipta for Patients with COPD Business Wire
Apr-03-18 09:42AM  Biotech Stock Tests Buy Zone, Gets New Approval For Asthma Drug Relvar Ellipta Investor's Business Daily
Mar-29-18 10:02AM  Flavor Of The Month: Innoviva And More Simply Wall St.
Mar-28-18 12:02PM  March Growth Stock Opportunities Simply Wall St.
Mar-09-18 06:02PM  Have Investors Priced In Innoviva Incs (NASDAQ:INVA) Growth? Simply Wall St.
Mar-08-18 03:00AM  GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma Business Wire
Mar-06-18 08:15AM  Report: Exploring Fundamental Drivers Behind Okta, Conduent, Innoviva, PRA Health Sciences, DDR, and Tenet Healthcare New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Feb-21-18 08:27AM  New Strong Sell Stocks for February 21st Zacks
Feb-19-18 02:40AM  How Do Analysts See Innoviva Inc (NASDAQ:INVA) Performing In The Years Ahead? Simply Wall St.
Feb-14-18 04:00AM  GSK Submits Landmark IMPACT Data to European Medicines Agency to Support Expanded Label for Trelegy Ellipta Business Wire
Feb-13-18 04:05PM  Why Innoviva Inc. Stock Jumped Tuesday Motley Fool +9.97%
11:38AM  Sarissa Capital Reconstitutes Innoviva Board Of Directors PR Newswire
Feb-12-18 10:01PM  Drug company Innoviva settles with activist hedge fund Sarissa -sources Reuters
Feb-09-18 02:09PM  Edited Transcript of INVA earnings conference call or presentation 8-Feb-18 10:00pm GMT Thomson Reuters StreetEvents +11.81%
Feb-08-18 07:07PM  Innoviva beats Street 4Q forecasts Associated Press
04:05PM  Innoviva Reports Record Fourth Quarter and Full Year 2017 Financial Results Business Wire
01:40PM  Innoviva, Inc. to Host Earnings Call ACCESSWIRE
Feb-02-18 04:05PM  Innoviva to Report Fourth Quarter Financial Results on February 8 at 5:00 p.m. EDT Business Wire
Jan-26-18 04:00AM  GSK Announces CHMP Positive Opinion for Labelling Update to Relvar Ellipta in Patients with Asthma Business Wire
Jan-09-18 08:02AM  See what the IHS Markit Score report has to say about Innoviva Inc. Markit
Jan-02-18 08:05AM  See what the IHS Markit Score report has to say about Innoviva Inc. Markit
Dec-30-17 05:45PM  Does Innoviva Incs (NASDAQ:INVA) PE Ratio Warrant A Buy? Simply Wall St.
Dec-27-17 03:00AM  Innoviva Sees RS Rating Rise To 74 Investor's Business Daily
Dec-22-17 03:00AM  Innoviva Earns Relative Strength Rating Upgrade Investor's Business Daily
Dec-21-17 11:32AM  ETFs with exposure to Innoviva, Inc. : December 21, 2017 Capital Cube
Dec-19-17 04:05PM  Innoviva and Sarissa Implement Court Order Business Wire
Dec-12-17 07:23AM  Innoviva, Inc. breached its 50 day moving average in a Bullish Manner : INVA-US : December 12, 2017 Capital Cube
Dec-08-17 08:05AM  See what the IHS Markit Score report has to say about Innoviva Inc. Markit
Dec-01-17 10:39AM  ETFs with exposure to Innoviva, Inc. : December 1, 2017 Capital Cube
Nov-30-17 09:44AM  Innoviva, Inc. :INVA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 30, 2017 Capital Cube
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a long-acting beta2 agonist (LABA), vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate (FF); ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA and LABA. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Brisbane, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bickerstaff GeorgeDirectorFeb 21Buy14.9010,000148,95838,762Feb 22 05:27 PM
HULME GEOFFREYInterim PEOFeb 15Buy14.807,000103,6007,000Feb 20 04:02 PM